CG
CNCR

Colony Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Colony Group’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$208K Buy
2023
Q2 		$245K Buy
2023
Q1 		– Sell
2022
Q4 		$242K Buy
2022
Q3 		– Sell
2022
Q2 		$317K Buy
2022
Q1 		$327K Buy